Please provide your email address to receive an email when new articles are posted on . Vancomycin, the only available glycopeptide antibiotic in the United States, continues to be a mainstay of ...
Until we have peer-reviewed publication of a prospective trial showing superiority of alternatives to vancomycin, its use will continue. The intent of the guidelines was to optimize vancomycin dosing ...
Aims: To analyze the results from the clinical monitoring of serum vancomycin levels among ICU pediatric patients. Methods: A retrospective drug utilization evaluation was performed for pediatric ...
ALBUQUERQUE, N.M. (KRQE) – Researchers at Sandia National Laboratories have created a wearable sensor patch capable of continuously monitoring the levels of the antibiotic vancomycin. The lab combined ...
Sandia National Laboratories has created a wearable sensor patch that uses microneedles and nanoscale sensors to continuously monitor the antibiotic vancomycin, offering real-time measurements and ...
COPENHAGEN, Denmark & BUFFALO GROVE, IL.--(BUSINESS WIRE)--Xellia Pharmaceuticals (‘Xellia’), a global leader in the manufacturing of specialty anti-infective treatments, announced today it has ...
Increased use of rapid diagnostic techniques such as PCR may allow prompt discontinuation of vancomycin when not indicated. Further development of alternative antimicrobials may also lessen its use.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results